Trial Profile
The Efficacy of Nebulized Procaterol Versus Nebulized Salbutamol for the Treatment of Moderate Acute Asthma: a Randomized, Double-blind, Parallel Group Study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Nov 2011
Price :
$35
*
At a glance
- Drugs Procaterol (Primary) ; Salbutamol
- Indications Acute asthma
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 01 Oct 2011 Primary endpoint 'Peak-expiratory-flow-rate' has not been met. Difference between treatment groups (3.9%) reached statistical significance (p<0.05) but did not reach pre-specified clinical significance criteria (5%).
- 08 Oct 2009 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).
- 12 Aug 2009 New trial record